William Geisler, MD, MPH is the Assistant Dean for Physician Scientist Development at the University of Alabama Birmingham (UAB), and he is the Director of the UAB STD Program. Dr. Geisler is board certified in internal medicine and infectious diseases. In addition to his current teaching, clinical, and research activities at UAB, Dr. Geisler has also served as a consultant to the CDC and WHO on several projects, including development of the STI Treatment Guidelines.
A magna cum laude and Phi Beta Kappa graduate of the University of Tennessee in Knoxville, Dr. Geisler completed his doctor of medicine degree at the University of Tennessee in Memphis, and later earned a master of public health degree in epidemiology from the University of Washington School of Public Health and Community Medicine in Seattle. Following an internal medicine internship and residency at the University of Michigan in Ann Arbor, Dr. Geisler served a fellowship at the Division of Allergy and Infectious Diseases at the University of Washington.
Dr. Geisler’s research program primarily investigates the influence of both biological characteristics of Chlamydia trachomatis and the human host immune-mediated responses and genetics on the clinical manifestations and outcomes of chlamydial infection. A major goal of his research program is to contribute to the development of an effective chlamydia vaccine. His research interests also include epidemiology, antibiotic resistance, and treatment of Mycoplasma genitalium infections. His clinical and teaching interests include the epidemiology, clinical manifestations, diagnosis, treatment, and prevention of sexually transmitted infections. Dr. Geisler is a teaching faculty for the AL-NC STD/HIV Prevention Training Center.